Vijay Vidyasagar is a Nephrology physician. OpenAlex indexes 6 publications with 275 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Dr
Morgantown, WV 265061200
Telephone
855-988-2273Provider last certified this registry record 11 Sept 2025.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.7%Vitamin D3 Analog18%Calcitriol100%Part D≥23 patientsCorticosteroid17.6%Prednisone100%Part D≥24 patients+ 1 more class in this area
Cardiovascular
25.6%Beta blocker10%Carvedilol100%Part D≥14 patientsCalcium channel blocker9.4%Amlodipine Besylate100%Part D≥14 patients+ 2 more classes in this area
Anti-infectives
16.2%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor9%Valganciclovir Hcl100%Part D≥17 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor3.7%Entecavir100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic Kidney Disease Stage Progression in Liver Transplant Recipients
Clinical Journal of the American Society of Nephrology
2011 - Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients.
PubMed
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”